#NephMadness 2023 – Prediction: IgA Nephropathy the Favorite to Win
Submit your picks! | NephMadness 2023 | #NephMadness | #IgAN Shikha Wadhwani @SWadhwaniMD Dr. Wadhwani is an Assistant Professor and Director of the Glomerular Disease [...]
immunosuppression
#NephMadness 2023: IgA Nephropathy Region
Submit your picks! | NephMadness 2023 | #NephMadness | #IgAN Selection Committee Member: Dana Rizk @DanaRizk1 Dana Rizk is Professor of Medicine in the Division of Nephrology [...]
Immunosuppressive Agents: An Interview
In a recent Core Curriculum published in AJKD, Sam Kant, Andreas Kronbichler, and Duvuru Geetha explore different classes of immunosuppressive drugs, how to choose [...]
Pregnancy and CKD: Making it Possible, and the Legacy of Dr Susan Hou
It took a strong woman to pioneer research in the field of women’s health and certainly Dr Susan Hou was one. During her career, she worked tirelessly to help us understand [...]
Transplant Practices During the COVID-19 Pandemic
In this author interview, AJKD Social Media Editor, Timothy Yau @Maximal_Change, talks to Krista Lentine @KristaLentine, Roslyn Mannon @mannonmom, and Michelle Josephson [...]
Test Your Knowledge: Management of Kidney Transplant Recipients
A recent Core Curriculum by Voora and Adey published in AJKD reviews the mechanisms of immunosuppression, types of rejection, complications of recurrent disease, common [...]
#NKFClinicals 2018: Approach to Common GNs – Can Less be More?
I’m usually a dialysis person, but was thrilled to leave my comfort zone and attend the Case-Based Approach to Managing Immunosuppression in Glomerular Disease session. [...]
ASERTAA: Towards Optimizing Tacrolimus-based Immunosuppression in African American Kidney Transplant Recipients
Tacrolimus was first discovered by scientists of the Fujisawa Pharmaceutical Company in a soil sample taken from the foot of Mount Tsukuba in Tokyo. Originally called [...]
Can I Switch My Kidney Transplant Patient from Tacrolimus to Belatacept?
A recent study by Grinyó et al published in AJKD reveal the three year results of a multicenter randomized controlled phase II trial where stable kidney transplant [...]
LCP-Tacrolimus: A Novel Extended-Release Tacrolimus for Use in Kidney Transplantation
Tacrolimus is the cornerstone of immunosuppression in solid organ transplantation. The SRTR annual data report from 2014 suggests that > 90% of kidney transplant [...]